INDRAPRASTHA MEDICAL Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Quarterly Results    (IRMED)

Here are the latest quarterly results of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL financial fact sheet and INDRAPRASTHA MEDICAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

INDRAPRASTHA MEDICAL Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,8942,0021,9822,0042,0372,1612,1042,005 
Other income Rs m11123212 
Turnover Rs m1,8952,0031,9832,0062,0402,1632,1052,007 
Expenses Rs m1,6991,7871,7781,8091,8101,9361,8681,830 
Gross profit Rs m195214204195227226236175 
Depreciation Rs m7576757281838482 
Interest Rs m1817181517151412 
Profit before tax Rs m10312211111013212913982 
Tax Rs m3846403947-503217 
Profit after tax Rs m657771718517910765 
Gross profit margin %10.310.710.39.711.110.411.28.7 
Effective tax rate %36.837.236.135.135.4-39.023.120.8 
Net profit margin %3.43.83.63.64.28.35.13.2 
Diluted EPS Rs 0.7 0.8 0.8 0.8 0.9 2.0 1.2 0.7  
Diluted EPS (TTM) Rs 2.5 2.8 2.9 3.1 3.3 4.4 4.8 4.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: INDRAPRASTHA MEDICAL 4QFY20 Result Performance Review

More Health Services Company Quarterly Results:   ALKEM LABORATORIES  WYETH  SHASUN PHARMA  BIOCON   CADILA HEALTHCARE  

Compare INDRAPRASTHA MEDICAL With:   ALKEM LABORATORIES  WYETH  SHASUN PHARMA  BIOCON   CADILA HEALTHCARE  

Compare INDRAPRASTHA MEDICAL With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Fell 540 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red.

Views on news

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About (Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Oct 26, 2020 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - APOLLO HOSPITALS COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS